Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India: Our Bureau, Mumbai ...

The event will be held virtually, allowing participants to join from anywhere in the world. This timely and insightful ...

Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...

EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia: Cambridge, UK Wednesday, April 30, 2025, 1 ...

Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma: Berlin Wednesday, April 30, 2025, 12:00 Hrs [IS ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

LIfT BioSciences, (LIfT), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, announces progress in advancing the planned clinical trial for their Immunomodulatory Alpha ...

AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer: Cambridge, UK Wednesday, April 30, 2025, 10:00 Hrs [IST] Ast ...

Merck breaks ground on new $1 billion biologics center of excellence in Wilmington, Delaware: Rahway, New Jersey Wednesday, April 30, 2025, 09:00 Hrs [IST] Merck, known as MSD out ...

Panel asks Ministry to ensure effective implementation of central sector scheme on medicinal plants: Gireesh Babu, New Delhi Wednesday, April 30, 2025, 08:00 Hrs [IST] The Parliam ...

Centre notifies new export norms for doxycycline 100 mg dispersible tablets: Shardul Nautiyal, Mumbai Wednesday, April 30, 2025, 08:00 Hrs [IST] In a significant move to streamlin ...

FOPE urges DCGI to review the list of 35 unapproved FDCs for manufacture and marketing: Nandita Vijayasimha, Bengaluru Wednesday, April 30, 2025, 08:00 Hrs [IST] The Federation of ...